Please assess the completion status of the following clinical trial:

Trial Title: A 14 Week Study of Mindfulness Effects on Attentional Control in Older Adults

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: BASIC_SCIENCE
- Time Perspective: None
- Masking: SINGLE
- Phase: None
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Able to provide informed consent and perform cognitive and behavioral (mindfulness) interventions;~* Time and willingness to commit to the completion of this study;~* Ability to read at an 8th grade level based on scores on the Wechsler Test of Adult Reading (WTAR) and reading text at 14 point font~Exclusion Criteria:~* Lack of time and willingness to commit to the completion of this 14-week study~* Less than an 8th grade education~* Having been told by a healthcare provider that they (1) have had a stroke or mini-stroke in the past 12 months, (2) have ever had a traumatic brain injury, (3) have had schizophrenia or psychosis, (4) have problem with alcohol or substance abuse~* extreme difficulty reading ordinary print in a newspaper, or have stopped reading due to poor eyesight.~* extreme difficulty hearing, or being completely unable to hear, ordinary speech in low-noise conditions, even with hearing aid.~* Currently participating in cognitive training or brain training~* Having participated in any cognitive or brain training study within the last 6 months~* Currently participating in yoga or meditation based practices

- Gender: ALL
- Minimum Age: 65 Years
- Maximum Age: None
- Healthy Volunteers: t

Study Arms:
- Brain Health (Type: ACTIVE_COMPARATOR): In weeks 1 and 14, participants receive: Montreal Cognitive Assessment (MoCA), Wechsler Test of Adult Reading (WTAR), Functional Activities Questionnaire (FAQ), Older Americans Resources and Services (OARS) Complete Activities of Daily Living Scale, The Short Form (36) Health Survey (SF-36), Attention measures (Attention Network Test (ANT); Continuous Performance Test (CPT); Auditory Dual Task (ADT); Mind wandering; Cued Stroop), Positive and Negative Affect Scale (PANAS), Geriatric Depression Scale (GDS), Mindfulness Attention Awareness Scale (MAAS), Five Facet Mindfulness Questionnaire (FFMQ), Emotion Regulation Questionnaire (ERQ), State-Trait Anxiety Inventory (STAI), and Starkstein Apathy Scale (AS). In weeks 4-11, participants receive the Brain Health control instruction.
- Mindfulness-inspired Treatment/Testing (Type: EXPERIMENTAL): Participants receive all of the same measures as the active comparator Brain Health condition in Weeks 1-14. In weeks 4-11, participants receive Mindfulness Inspired Treatment

Based on this trial design, predict the completion outcome and termination type (if applicable).